Inventor
AGBANDJE-MCKENNA MAVIS
US34 patents
⚠️ This page may combine multiple inventors who share the name “AGBANDJE-MCKENNA MAVIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV FLORIDA
24 patentsUS10011640B2Jul 3, 2018
Capsid-modified rAAV vector compositions and methods therefor
UNIV FLORIDA42 citations97
US9920097B2Mar 20, 2018
Capsid-modified rAAV vector compositions having improved transduction efficiencies, and methods of use
UNIV FLORIDA31 citations97
US9775918B2Oct 3, 2017
Capsid-modified rAAV vectors and methods of use
UNIV FLORIDA48 citations97
US9725485B2Aug 8, 2017
AAV vectors with high transduction efficiency and uses thereof for gene therapy
UNIV FLORIDA62 citations97
US9611302B2Apr 4, 2017
High-transduction-efficiency RAAV vectors, compositions, and methods of use
UNIV FLORIDA67 citations97
US9157098B2Oct 13, 2015
Transduction efficiency, capsid-modified rAAV vectors and methods of use
UNIV FLORIDA33 citations97
US8802440B2Aug 12, 2014
Therapeutic methods based on tyrosine-substituted, capsid-modified rAAV vectors
UNIV FLORIDA37 citations97
US10426844B2Oct 1, 2019
Capsid-mutated rAAV vectors and methods of use
UNIV FLORIDA24 citations94
US10294281B2May 21, 2019
High-transduction-efficiency rAAV vectors, compositions, and methods of use
UNIV FLORIDA21 citations93
US10723768B2Jul 28, 2020
Capsid modified rAAV vectors and methods of use
UNIV FLORIDA9 citations92
US10934327B2Mar 2, 2021
Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer
UNIV FLORIDA6 citations84
US10815279B2Oct 27, 2020
Capsid-modified rAAV vector compositions and methods therefor
UNIV FLORIDA10 citations84
US11124544B2Sep 21, 2021
AAV vectors with high transduction efficiency and uses thereof for gene therapy
UNIV FLORIDA4 citations83
US10308957B2Jun 4, 2019
rAAV vectors and methods for transduction of photoreceptors and RPE cells
UNIV FLORIDA13 citations83
US12065467B2Aug 20, 2024
High-transduction-efficiency rAAV vectors, compositions, and methods of use
UNIV FLORIDA2 citations72
US11434260B2Sep 6, 2022
High-transduction-efficiency rAAV vectors, compositions, and methods of use
UNIV FLORIDA3 citations72
US10927150B2Feb 23, 2021
Recombinant AAV1, AAV5, and AAV6 capsid mutants and uses thereof
UNIV FLORIDA5 citations72
US11091777B2Aug 17, 2021
Synthetic combinatorial AAV capsid library for targeted gene therapy
UNIV FLORIDA2 citations71
US12358954B2Jul 15, 2025
Capsid-modified rAAV vector compositions and methods therefor
UNIV FLORIDA1 citations64
US12570699B2Mar 10, 2026
Capsid-modified, rAAV3 vector compositions and methods of use in gene therapy of human liver cancer
UNIV FLORIDA0 citations62
US12163152B2Dec 10, 2024
AAV chimeras
UNIV FLORIDA0 citations59
US12018050B2Jun 25, 2024
AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties
UNIV FLORIDA0 citations59
US11905524B2Feb 20, 2024
AAV chimeras
UNIV FLORIDA1 citations59
US11078238B2Aug 3, 2021
AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties
UNIV FLORIDA1 citations59
UNIV NORTH CAROLINA CHAPEL HILL
4 patentsUS11208438B2Dec 28, 2021
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL5 citations80
US10745447B2Aug 18, 2020
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL8 citations80
US11840555B2Dec 12, 2023
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL1 citations69
US12281320B2Apr 22, 2025
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL0 citations56